An alternative exact solution of the two-stage clonal growth model of cancer

Risk Analysis

Volumn 19, Issue 1, 1999, Pages 9-14

  Hoogenveen, Rudolf T ^a   Clewell, Harvey J ^b   Andersen, Melvin E ^b   Slob, Wout ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b ICF INTERNATIONAL   (United States)

Author keywords

Approximate solution; Cancer model; Cell proliferation; Hazard rate; MVK model; Two stage model

Indexed keywords

APPROXIMATION THEORY; COMPUTER SIMULATION; DIFFERENTIAL EQUATIONS; DISEASES; INTEGRATION; MATHEMATICAL MODELS; PROBLEM SOLVING;

CANCER MODEL; CLONAL EXPANSION MODEL; MOOLGAVKAR-VENZON-KNUDSON MODEL;

RISK ASSESSMENT;

ACCURACY; ARTICLE; ASSAY; CANCER GROWTH; CLONOGENESIS; COMPUTER SIMULATION; HUMAN; HUMAN CELL; INCIDENCE; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; PREVALENCE;

EID: 0032962756     PISSN: 02724332     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1539-6924.1999.tb00381.x     Document Type: Article

References (14)

1. A. G. Knudson, "Mutation and Cancer: Statistical Study of Retinoblastoma," Proc. Natl. Acad. Sci. USA 68, 820-823 (1971).
2. S. H. Moolgavkar and D. J. Venzon, "Two-Event Models for Carcinogenesis: Incidence Curves for Childhood and Adult Tumors," Math. Biosci. 47, 55-77 (1979).
3. S. H. Moolgavkar, A. Dewanji, and G. Luebeck, "Cigarette Smoking and Lung Cancer: Reanalysis of the British Doctors' Data," J. Natl. Cancer Inst. 81, 415-420 (1989).
4. S. H. Moolgavkar, F. T. Cross, G. Luebeck, and G. E. Dagle, "A Two-Mutation Model for Radon-Induced Lung Tumors in Rats," Radiat. Res. 121, 28-37 (1990).
5. S. H. Moolgavkar, E. G. Luebeck, M. De Gunst, R. E. Port, and M. Schwarz, "Quantitative Analysis of Enzyme-Altered Foci in Rat Hepatocarcinogenesis Experiments - I. Single Agent Regimen. Carcinogenesis 11, 1271-1278 (1990).
6. S. H. Moolgavkar and E. G. Luebeck, "Multistage Carcinogenesis: Population-Based Model for Colon Cancer," J. Natl. Cancer Inst. 84, 610-618 (1992).
7. C. J. Portier, S. D. Sherman, M. Kohn, L. Edler, A. Kopp-Schneider, R. M. Maronpot, and G. Lucier, "Modeling the Number and Size of Hepatic Focal Lesions Following Exposure to 2,3,7,8-TCDD," Toxicol. Appl. Pharmacol. 138, 20-30 (1996).
8. S. H. Moolgavkar, E. G. Luebeck, A. Buchmann, and K. W. Bock, "Quantitative Analysis of Enzyme-Altered Liver Foci in Rats Initiated with Diethylnitrosamine and Promoted with 2,3,7,8-Tetrachlorodibenzo-p-dioxin or 1,2,3,4,6,7,8-Hepatochlorodibenzo-p-dioxin," Toxicol. Appl. Pharmacol. 138, 31-42 (1996).
9. S. H. Moolgavkar, A. Dewanji, and D. J. Venzon, "A Stochastic Two-Stage Model for Cancer Risk Assessment. I: The Hazard Function and Probability of Tumor," Risk Anal. 8, 383-392 (1988).
10. S. H. Moolgavkar and G. Luebeck, "Two-Event Model for Carcinogenesis: Biological, Mathematical and Statistical Considerations," Risk Anal. 10, 323-341 (1990).
11. W. F. Heidenreich, E. G. Luebeck, and S. H. Moolgavkar, "Some Properties of the Hazard Function of the Two-Mutation Clonal Expansion Model," Risk Anal. 17, 391-399 (1997).
12. H. J. Clewell III, D. W. Quinn, M. E. Andersen, and R. B. Conolly, "An Improved Appoximation to the Exact Solution of the Two-Stage Clonal Growth Model of Cancer," Risk Anal. 15, 467-473 (1995).
13. A. Kopp-Schneider, C. J. Portier, and C. D. Sherman, "The Exact Formula for Tumor Incidence in the Two-Stage Model," Risk Anal. 14, 1079-1080 (1994).
14. D. W. Quinn, "Calculating the Hazard Function and Probability of Tumor for Cancer Risk Assessment When the Parameters Are Time-Dependent," Risk Anal. 9, 407-413 (1989).